非凡中國(08032.HK)附屬出售揚州土地權益 料收益4,670萬元
非凡中國(08032.HK)公布,公司非全資附屬非凡中國揚州社區開發,向買方揚州市華城房地產開發,出售目標公司揚州非凡房地產開發全部已發行股本,代價為3.14億元人民幣。
目標公司主要從事物業開發和銷售、物業租賃、資產管理、室內外設計及翻新、建築設備及材料的批發以及酒店管理。目標公司亦持有位於江蘇省揚州市廣陵新城的土地,總面積為2.33萬平方米,而該土地目前空置。
公司預計將確認未經審核收益約4,670萬港元。出售事項產生的所得款項淨額約為3.58億港元,現時擬用於公司管理層認為合適的機遇出現時集團可能進行的收購事項;及集團的一般營運資金。(ek/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.